Cargando…

Comparison of the clinical impact of 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers in patients suspected of Alzheimer’s disease

BACKGROUND: The two biomarkers 2-[(18)F]FDG-PET and cerebrospinal fluid biomarkers are both recommended to support the diagnosis of Alzheimer’s disease. However, there is a lack of knowledge for the comparison of the two biomarkers in a routine clinical setting. OBJECTIVE: The aim was to compare the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gjerum, Le, Andersen, Birgitte Bo, Bruun, Marie, Simonsen, Anja Hviid, Henriksen, Otto Mølby, Law, Ian, Hasselbalch, Steen Gregers, Frederiksen, Kristian Steen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954298/ https://www.ncbi.nlm.nih.gov/pubmed/33711065 http://dx.doi.org/10.1371/journal.pone.0248413

Ejemplares similares

Evaluating 2-[(18)F]FDG-PET in differential diagnosis of dementia using a data-driven decision model
por: Gjerum, Le, et al.
Publicado: (2020)

Hybrid FDG PET/MRI vs. FDG PET and CT in patients with suspected dementia – A comparison of diagnostic yield and propagated influence on clinical diagnosis and patient management
por: Kaltoft, Nicolai Stefan, et al.
Publicado: (2019)

A zero-dose synthetic baseline for the personalized analysis of [(18)F]FDG-PET: Application in Alzheimer’s disease
por: Hinge, Christian, et al.
Publicado: (2022)

Lactoferrin in cerebrospinal fluid and saliva is not a diagnostic biomarker for Alzheimer's disease in a mixed memory clinic population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

Estimation of brain amyloid accumulation using deep learning in clinical [(11)C]PiB PET imaging
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2023)

Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease
por: Jensen, Camilla Steen, et al.
Publicado: (2017)

Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer’s Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time
por: Musaeus, Christian Sandøe, et al.
Publicado: (2023)

Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and Perspectives
por: Jensen, Camilla Steen, et al.
Publicado: (2015)

Prognostic value of complementary biomarkers of neurodegeneration in a mixed memory clinic cohort
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Biomarkers for Alzheimer's Disease in Saliva: A Systematic Review
por: Gleerup, Helena Sophia, et al.
Publicado: (2019)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2023)

Differential proteomic profile of lumbar and ventricular cerebrospinal fluid
por: Rostgaard, Nina, et al.
Publicado: (2023)

Are CSF Biomarkers Useful as Prognostic Indicators in Diagnostically Unresolved Cognitively Impaired Patients in a Normal Clinical Setting
por: Schjønning Nielsen, Malene, et al.
Publicado: (2016)

Quantitative Electroencephalography Analyzed by Statistical Pattern Recognition as a Diagnostic and Prognostic Tool in Mild Cognitive Impairment: Results from a Nordic Multicenter Cohort Study
por: Schjønning Nielsen, Malene, et al.
Publicado: (2018)

Cerebrospinal fluid osmolality cannot predict development or surgical outcome of idiopathic normal pressure hydrocephalus
por: Oernbo, Eva Kjer, et al.
Publicado: (2022)

Resting State EEG in Exercise Intervention Studies: A Systematic Review of Effects and Methods
por: Gramkow, Mathias Holsey, et al.
Publicado: (2020)

Effects of aerobic exercise on event-related potentials related to cognitive performance: a systematic review
por: Gusatovic, Julia, et al.
Publicado: (2022)

Physical Exercise May Increase Plasma Concentration of High-Density Lipoprotein-Cholesterol in Patients With Alzheimer’s Disease
por: Jensen, Camilla Steen, et al.
Publicado: (2020)

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study
por: Knorr, Ulla, et al.
Publicado: (2019)

Patients with Alzheimer's disease who carry the APOE ε4 allele benefit more from physical exercise
por: Jensen, Camilla Steen, et al.
Publicado: (2019)

A 16-Week Aerobic Exercise Intervention Does Not Affect Hippocampal Volume and Cortical Thickness in Mild to Moderate Alzheimer’s Disease
por: Frederiksen, Kristian Steen, et al.
Publicado: (2018)

Hashimoto's encephalopathy: Follow‐up data from neuropsychology, lumbar puncture, and FDG‐PET
por: Lagström, Ronja Maria Birgitta, et al.
Publicado: (2019)

Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics
por: Thorlacius-Ussing, Gorm, et al.
Publicado: (2021)

Moderate- to high-intensity exercise does not modify cortical β-amyloid in Alzheimer's disease
por: Frederiksen, Kristian S., et al.
Publicado: (2019)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

C9ORF72 hexanucleotide repeat expansion with Alzheimer's disease‐like clinical phenotype: A case report with results from neuropsychology, CSF, FDG‐PET, and PiB‐PET
por: Filikci, Zuhal, et al.
Publicado: (2020)

Abnormal [18F]FDG PET/MRI findings in paraspinal structures of patients with suspected cerebrospinal fluid leak
por: Yoon, Daehyun, et al.
Publicado: (2021)

Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer’s disease
por: Delgado-Peraza, Francheska, et al.
Publicado: (2023)

DeepDixon synthetic CT for [(18F]FET) PET/MRI attenuation correction of post-surgery glioma patients with metal implants
por: Ladefoged, Claes Nøhr, et al.
Publicado: (2023)

Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort
por: Muurling, Marijn, et al.
Publicado: (2020)

The Added Value of Cerebrospinal Fluid Neurofilament Light Chain to Existing Diagnostic Methods and Biomarkers in a Mixed Memory Clinic Cohort of Consecutive Patients
por: Gleerup, Helena Sophia, et al.
Publicado: (2022)

Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer’s disease and mild cognitive impairment
por: Poulsen, Keld, et al.
Publicado: (2014)

Inflammatory Markers in Cerebrospinal Fluid from Patients with Hydrocephalus: A Systematic Literature Review
por: Lolansen, Sara Diana, et al.
Publicado: (2021)

Quantification and accuracy of clinical [11C]-PiB PET/MRI: the effect of MR-based attenuation correction
por: Law, Ian, et al.
Publicado: (2014)

Cost-effectiveness of a randomised trial of physical activity in Alzheimer’s disease: a secondary analysis exploring patient and proxy-reported health-related quality of life measures in Denmark
por: Sopina, Elizaveta, et al.
Publicado: (2017)

Sleep Dysregulation Is Associated with (18)F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
por: Fernandes, Mariana, et al.
Publicado: (2023)

Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure
por: Oernbo, Eva K., et al.
Publicado: (2022)

Detecting frontotemporal dementia syndromes using MRI biomarkers
por: Bruun, Marie, et al.
Publicado: (2019)

The role of physical and cognitive function in performance of activities of daily living in patients with mild-to-moderate Alzheimer’s disease – a cross-sectional study
por: Clemmensen, Frederikke K, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_62rkuglg55d2bgr8c1gf5tc7v1